Přehled o publikaci
2024
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma
PRUTSCH, Nicole; Shuning HE; Alla BEREZOVSKAYA; Adam D DURBIN; Neekesh V DHARIA et. al.Základní údaje
Originální název
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma
Autoři
PRUTSCH, Nicole; Shuning HE; Alla BEREZOVSKAYA; Adam D DURBIN; Neekesh V DHARIA; Kelsey A MAHER; Jamie D MATTHEWS; Lucy HARE; Suzanne Dawn TURNER; Kimberly STEGMAIER; Lukas KENNER; Olaf MERKEL; A Thomas LOOK; Brian J ABRAHAM a Mark W ZIMMERMAN
Vydání
CELL REPORTS MEDICINE, AMSTERDAM, ELSEVIER, 2024, 2666-3791
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Organizace
Lékařská fakulta – Masarykova univerzita – Repozitář
UT WoS
001222093700001
EID Scopus
2-s2.0-85188151080
Klíčová slova anglicky
anaplastic large cell lymphoma; STAT3
Návaznosti
LX22NPO5102, projekt VaV.
Změněno: 12. 6. 2024 04:49, RNDr. Daniel Jakubík
Anotace
V originále
Anaplastic large cell lymphoma (ALCL) is an aggressive, CD30 + T cell lymphoma of children and adults. ALK fusion transcripts or mutations in the JAK-STAT pathway are observed in most ALCL tumors, but the mechanisms underlying tumorigenesis are not fully understood. Here, we show that dysregulated STAT3 in ALCL cooccupies enhancers with master transcription factors BATF3, IRF4, and IKZF1 to form a core regulatory circuit that establishes and maintains the malignant cell state in ALCL. Critical downstream targets of this network in ALCL cells include the protooncogene MYC , which requires active STAT3 to facilitate high levels of MYC transcription. The core autoregulatory transcriptional circuitry activity is reinforced by MYC binding to the enhancer regions associated with STAT3 and each of the core regulatory transcription factors. Thus, activation of STAT3 provides the crucial link between aberrant tyrosine kinase signaling and the core transcriptional machinery that drives tumorigenesis and creates therapeutic vulnerabilities in ALCL.